Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 57,500
+1,300 (2.31%)
At close: Mar 18, 2026
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.91 trillion as of March 18, 2026. Its market cap has increased by 46.07% in one year.
Market Cap
2.91T
Enterprise Value
2.92T
Revenue
155.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
57,500.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.91T, an increase of 10,983.04%. That is a compound annual growth rate of 16.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 2.85T | 28.46% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 7.38T |
| Hanmi Pharm. | 6.30T |
| Celltrion Pharm | 2.67T |
| Daewoong Pharmaceutical | 1.92T |
| GC Biopharma | 1.74T |
| Chong Kun Dang Pharmaceutical | 1.12T |
| Ildong Pharmaceutical | 1.03T |
| Daewoong | 973.20B |